Climate change is accelerating the melting of the world's mountain glaciers, according to a massive new study that found them ...

(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Copenhagen stepped up its defense budget amid Trump’s campaign to buy Greenland and determination to strike a deal with ...

European Union trade chief Maros Sefcovic said on Thursday that his top priority in trade talks with President Donald Trump's ...

Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.

Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. Here are two important insights from that call that should excite investors about ...

Backed by Science, Inspired by Nature - Mitolyn Delivers Mitochondria-Supporting Ingredients for Optimal Health NEW YORK CITY, NEW YORK / ACCESSWIRE / February ...

Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...